From: DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population
Clinical parameters | Â | Distribution (%) |
---|---|---|
Age (years) | 20 to 40 | 2.30 |
41 to 60 | 31.70 | |
61 to >80 | 66.10 | |
Breast cancer diagnosis | Right breast | 47.10 |
Left breast | 46.10 | |
Both | 6.80 | |
Histology | Ductal | 67.40 |
Lobular | 15.40 | |
DCIS | 6.40 | |
LCIS | 1.80 | |
Mixed and other tumor types | 9.00 | |
TNM stage | I | 36.70 |
IIa | 24.40 | |
IIb | 10.90 | |
IIIa | 8.60 | |
IIIb | 5.00 | |
IIIc | 8.10 | |
IV | 6.30 | |
ER status | Positive | 82.40 |
Negative | 17.60 | |
PR status | Positive | 72.40 |
Negative | 27.60 | |
HER2 status | Positive | 14.00 |
Negative | 67.00 | |
Not defined | 19.00 | |
Response of chemotherapy | No chemotherapy/data | 48.00 |
Complete remission | 32.10 | |
Recurrence | 5.90 | |
Stable disease | 8.10 | |
Progress | 5.90 | |
Survival | Not detected | 10.90 |
Alive | 76.00 | |
Death | 13.10 |